A far cry
After a long wait, the Indian Pharmacopoeia Comm-ission went operational recently.

Implications for generic drug manufacturers
Though the generics market is largely risk free, the segment not only faces intellectual property related challenges but market challenges too, say Parikshit Bansal and Anand Sharma in the second part of the article